2022-07-012023-06-302023-06-30false12668056ISN MEDICAL LTD2024-03-1246190iso4217:GBPxbrli:pure126680562022-07-01126680562023-06-30126680562022-07-012023-06-30126680562021-07-01126680562022-06-30126680562021-07-012022-06-3012668056bus:SmallEntities2022-07-012023-06-3012668056bus:AuditExempt-NoAccountantsReport2022-07-012023-06-3012668056bus:FullAccounts2022-07-012023-06-3012668056bus:PrivateLimitedCompanyLtd2022-07-012023-06-3012668056core:WithinOneYear2023-06-3012668056core:AfterOneYear2023-06-3012668056core:WithinOneYear2022-06-3012668056core:AfterOneYear2022-06-3012668056core:ShareCapital2023-06-3012668056core:SharePremium2023-06-3012668056core:RevaluationReserve2023-06-3012668056core:OtherReservesSubtotal2023-06-3012668056core:RetainedEarningsAccumulatedLosses2023-06-3012668056core:ShareCapital2022-06-3012668056core:SharePremium2022-06-3012668056core:RevaluationReserve2022-06-3012668056core:OtherReservesSubtotal2022-06-3012668056core:RetainedEarningsAccumulatedLosses2022-06-3012668056core:LandBuildings2023-06-3012668056core:PlantMachinery2023-06-3012668056core:Vehicles2023-06-3012668056core:FurnitureFittings2023-06-3012668056core:OfficeEquipment2023-06-3012668056core:NetGoodwill2023-06-3012668056core:IntangibleAssetsOtherThanGoodwill2023-06-3012668056core:ListedExchangeTraded2023-06-3012668056core:UnlistedNon-exchangeTraded2023-06-3012668056core:LandBuildings2022-06-3012668056core:PlantMachinery2022-06-3012668056core:Vehicles2022-06-3012668056core:FurnitureFittings2022-06-3012668056core:OfficeEquipment2022-06-3012668056core:NetGoodwill2022-06-3012668056core:IntangibleAssetsOtherThanGoodwill2022-06-3012668056core:ListedExchangeTraded2022-06-3012668056core:UnlistedNon-exchangeTraded2022-06-3012668056core:LandBuildings2022-07-012023-06-3012668056core:PlantMachinery2022-07-012023-06-3012668056core:Vehicles2022-07-012023-06-3012668056core:FurnitureFittings2022-07-012023-06-3012668056core:OfficeEquipment2022-07-012023-06-3012668056core:NetGoodwill2022-07-012023-06-3012668056core:IntangibleAssetsOtherThanGoodwill2022-07-012023-06-3012668056core:ListedExchangeTraded2022-07-012023-06-3012668056core:UnlistedNon-exchangeTraded2022-07-012023-06-3012668056core:MoreThanFiveYears2022-07-012023-06-3012668056core:Non-currentFinancialInstruments2023-06-3012668056core:Non-currentFinancialInstruments2022-06-3012668056dpl:CostSales2022-07-012023-06-3012668056dpl:DistributionCosts2022-07-012023-06-3012668056core:LandBuildings2022-07-012023-06-3012668056core:PlantMachinery2022-07-012023-06-3012668056core:Vehicles2022-07-012023-06-3012668056core:FurnitureFittings2022-07-012023-06-3012668056core:OfficeEquipment2022-07-012023-06-3012668056dpl:AdministrativeExpenses2022-07-012023-06-3012668056core:NetGoodwill2022-07-012023-06-3012668056core:IntangibleAssetsOtherThanGoodwill2022-07-012023-06-3012668056dpl:GroupUndertakings2022-07-012023-06-3012668056dpl:ParticipatingInterests2022-07-012023-06-3012668056dpl:GroupUndertakingscore:ListedExchangeTraded2022-07-012023-06-3012668056core:ListedExchangeTraded2022-07-012023-06-3012668056dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-07-012023-06-3012668056core:UnlistedNon-exchangeTraded2022-07-012023-06-3012668056dpl:CostSales2021-07-012022-06-3012668056dpl:DistributionCosts2021-07-012022-06-3012668056core:LandBuildings2021-07-012022-06-3012668056core:PlantMachinery2021-07-012022-06-3012668056core:Vehicles2021-07-012022-06-3012668056core:FurnitureFittings2021-07-012022-06-3012668056core:OfficeEquipment2021-07-012022-06-3012668056dpl:AdministrativeExpenses2021-07-012022-06-3012668056core:NetGoodwill2021-07-012022-06-3012668056core:IntangibleAssetsOtherThanGoodwill2021-07-012022-06-3012668056dpl:GroupUndertakings2021-07-012022-06-3012668056dpl:ParticipatingInterests2021-07-012022-06-3012668056dpl:GroupUndertakingscore:ListedExchangeTraded2021-07-012022-06-3012668056core:ListedExchangeTraded2021-07-012022-06-3012668056dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2021-07-012022-06-3012668056core:UnlistedNon-exchangeTraded2021-07-012022-06-3012668056core:NetGoodwill2023-06-3012668056core:IntangibleAssetsOtherThanGoodwill2023-06-3012668056core:LandBuildings2023-06-3012668056core:PlantMachinery2023-06-3012668056core:Vehicles2023-06-3012668056core:FurnitureFittings2023-06-3012668056core:OfficeEquipment2023-06-3012668056core:AfterOneYear2023-06-3012668056core:WithinOneYear2023-06-3012668056core:ListedExchangeTraded2023-06-3012668056core:UnlistedNon-exchangeTraded2023-06-3012668056core:ShareCapital2023-06-3012668056core:SharePremium2023-06-3012668056core:RevaluationReserve2023-06-3012668056core:OtherReservesSubtotal2023-06-3012668056core:RetainedEarningsAccumulatedLosses2023-06-3012668056core:NetGoodwill2022-06-3012668056core:IntangibleAssetsOtherThanGoodwill2022-06-3012668056core:LandBuildings2022-06-3012668056core:PlantMachinery2022-06-3012668056core:Vehicles2022-06-3012668056core:FurnitureFittings2022-06-3012668056core:OfficeEquipment2022-06-3012668056core:AfterOneYear2022-06-3012668056core:WithinOneYear2022-06-3012668056core:ListedExchangeTraded2022-06-3012668056core:UnlistedNon-exchangeTraded2022-06-3012668056core:ShareCapital2022-06-3012668056core:SharePremium2022-06-3012668056core:RevaluationReserve2022-06-3012668056core:OtherReservesSubtotal2022-06-3012668056core:RetainedEarningsAccumulatedLosses2022-06-3012668056core:NetGoodwill2021-07-0112668056core:IntangibleAssetsOtherThanGoodwill2021-07-0112668056core:LandBuildings2021-07-0112668056core:PlantMachinery2021-07-0112668056core:Vehicles2021-07-0112668056core:FurnitureFittings2021-07-0112668056core:OfficeEquipment2021-07-0112668056core:AfterOneYear2021-07-0112668056core:WithinOneYear2021-07-0112668056core:ListedExchangeTraded2021-07-0112668056core:UnlistedNon-exchangeTraded2021-07-0112668056core:ShareCapital2021-07-0112668056core:SharePremium2021-07-0112668056core:RevaluationReserve2021-07-0112668056core:OtherReservesSubtotal2021-07-0112668056core:RetainedEarningsAccumulatedLosses2021-07-0112668056core:AfterOneYear2022-07-012023-06-3012668056core:WithinOneYear2022-07-012023-06-3012668056core:Non-currentFinancialInstrumentscore:CostValuation2022-07-012023-06-3012668056core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-07-012023-06-3012668056core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-07-012023-06-3012668056core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-07-012023-06-3012668056core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-07-012023-06-3012668056core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-07-012023-06-3012668056core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-07-012023-06-3012668056core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-07-012023-06-3012668056core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-07-012023-06-3012668056core:Non-currentFinancialInstrumentscore:CostValuation2023-06-3012668056core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-06-3012668056core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-06-3012668056core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-06-3012668056core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-06-3012668056core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-06-3012668056core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-06-3012668056core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-06-3012668056core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-06-3012668056core:Non-currentFinancialInstrumentscore:CostValuation2022-06-3012668056core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-06-3012668056core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-06-3012668056core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-06-3012668056core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-06-3012668056core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-06-3012668056core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-06-3012668056core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-06-3012668056core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-06-3012668056bus:Director12022-07-012023-06-3012668056core:FurnitureFittingsToolsEquipment2022-06-3012668056core:FurnitureFittingsToolsEquipment2023-06-3012668056core:FurnitureFittingsToolsEquipment2022-07-012023-06-30

ISN MEDICAL LTD

Registered Number
12668056
(England and Wales)

Unaudited Financial Statements for the Year ended
30 June 2023

ISN MEDICAL LTD
Company Information
for the year from 1 July 2022 to 30 June 2023

Director

JENKINS, Mark Alexander

Registered Address

Whiteleaf Business Centre
11 Little Balmer
Buckingham
MK18 1TF

Registered Number

12668056 (England and Wales)
ISN MEDICAL LTD
Balance Sheet as at
30 June 2023

Notes

2023

2022

£

£

£

£

Fixed assets
Tangible assets39201,313
9201,313
Current assets
Debtors5,4456,001
Cash at bank and on hand1838,869
5,62814,870
Creditors amounts falling due within one year4(6,348)(12,974)
Net current assets (liabilities)(720)1,896
Total assets less current liabilities2003,209
Provisions for liabilities5(174)(249)
Net assets262,960
Capital and reserves
Called up share capital11
Profit and loss account252,959
Shareholders' funds262,960
The financial statements were approved and authorised for issue by the Director on 12 March 2024, and are signed on its behalf by:
JENKINS, Mark Alexander
Director
Registered Company No. 12668056
ISN MEDICAL LTD
Notes to the Financial Statements
for the year ended 30 June 2023

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Revenue from sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

Straight line (years)
Fixtures and fittings4
Office Equipment3
2.Average number of employees

20232022
Average number of employees during the year11
3.Tangible fixed assets

Fixtures & fittings

Office Equipment

Total

£££
Cost or valuation
At 01 July 221,0174161,433
At 30 June 231,0174161,433
Depreciation and impairment
At 01 July 228535120
Charge for year254139393
At 30 June 23339174513
Net book value
At 30 June 23678242920
At 30 June 229323811,313
4.Creditors: amounts due within one year

2023

2022

££
Taxation and social security2,59812,474
Other creditors3,750500
Total6,34812,974
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
5.Provisions for liabilities

2023

2022

££
Net deferred tax liability (asset)174249
Total174249